Skip to main content
logo
Skybiotech Healthcare Limited (BOM:512036)
India flag India · Delayed Price · Currency is INR
120.00
-0.80 (-0.66%)
At close: Sep 15, 2026

Skybiotech Healthcare Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
55.3571.7172.7420.020.540.23
Revenue Growth
-41.76%-1.41%263.26%3597.53%138.36%16.26%
Gross Profit
25.4230.8935.0120.020.540.23
Operating Income
-22.04-18.58-24.1418.75-0.07-0.38
Net Income
-16.72-11.17-23.6915.35-0.07-0.38
Earnings Per Share
-7.46-6.70-14.188.02-0.07-0.36
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Short-Term Investments
-5.94-5.94-2.6984.330.170.12
Total Debt
84.1584.1571.98---
Net Cash (Debt)
-90.1-90.1-74.6784.330.170.12
Net Cash Growth
---48132.08%49.45%-33.85%
Net Cash Per Share
-40.21-54.05-44.7044.040.170.11

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
--15.16-10.42-13.37-3.736.1
Capital Expenditures
--0.02-3.26---
Free Cash Flow
--15.18-13.68-13.37-3.736.1
Free Cash Flow Growth
------52.37%

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
45.92%43.08%48.13%100.00%100.00%100.00%
Operating Margin
-39.82%-25.91%-33.18%93.64%-13.62%-166.50%
Pretax Margin
-40.14%-23.24%-33.35%93.64%-13.62%-166.50%
Profit Margin
-30.20%-15.57%-32.57%76.68%-13.37%-166.58%
FCF Margin
--21.17%-18.80%-66.76%-688.68%2683.86%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
---16.24--
P/FCF Ratio
-----4.26
PS Ratio
4.184.114.3112.4565.55114.44